Crewe Advisors’s Janux Therapeutics JANX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-115	Closed	-$1.39K	–	954
2023 Q1	$1.39K	Hold	115	–	–	﹤0.01%	739
2022 Q4	$1.52K	Hold	115	–	–	﹤0.01%	875
2022 Q3	$2K	Hold	115	–	–	﹤0.01%	1049
2022 Q2	$1K	Buy	+115	New	+$1K	﹤0.01%	1078